An extensive analysis shows scant evidence that ketamine or other NMDA receptor agonists reduce chronic noncancer pain but ...

A major Cochrane review found no convincing evidence that ketamine or similar NMDA-blocking drugs improve chronic non-cancer ...

The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found.

A Cochrane review assessed ketamine and other NMDA receptor antagonists for chronic non-cancer pain. The evidence was low to very low certainty, showing no clear pain relief and potential adverse ...

A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions ...

It’s a strong tranquilliser that’s historically been used as an anaesthetic in hospitals and vets, but recent data suggests that ketamine has become a popular party drug with Gen Z. Latest ...